Open AccessClinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
Author(s) -
Trimarchi Matteo,
Indelicato Pietro,
Vinciguerra Alessandro,
Bussi Mario
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3792
Subject(s) - dupilumab , medicine , chronic rhinosinusitis , nasal polyps , clinical trial , sinusitis , dermatology , clinical efficacy , disease , randomized controlled trial , surgery , intensive care medicine , atopic dermatitis
Abstract Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.